Apalutamide: A new agent in the management of prostate cancer

May, MB; Glode, AE

May, MB (reprint author), Baptist Hlth Lexington, Dept Pharm, 1700 Nicholasville Rd, Lexington, KY 40503 USA.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019; 25 (8): 1968

Abstract

Apalutamide is a competitive inhibitor of the androgen receptor and binds directly to the ligand-binding domain. The US Food and Drug Administration a......

Full Text Link